Clinical Trial: A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT04643067) titled 'A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients' on Nov. 12.

Brief Summary: SYNOPSIS

Study Title

A phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and preliminary efficacy of KPG-818 in patients with mild to moderate systemic lupus erythematosus

Brief Title:

Phase 1b/2a study to evaluate safety and efficacy of KPG-818 in SLE

Objectives

Phase 1b

The primary objectives of the study are:

* to assess the safety and tolerability of multiple oral doses of KPG-818 in patients with mild to mo...